Evidence map›Paper›PMID 28969089›Full record

ArticleOncotarget2017

Neutrophil count and percentage: potential independent prognostic indicators for advanced cancer patients in a palliative care setting.

Weiwei Zhao, Peng Wang, Huixun Jia, Menglei Chen, Xiaoli Gu, Minghui Liu, Zhe Zhang, Wenwu Cheng, Zhenyu Wu

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Oncotarget, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Weiwei Zhao *Department of Integrated Therapy, Fudan University Shanghai Cancer Center, Shanghai, China.
Peng Wang *Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
Huixun JiaDepartment of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
Menglei ChenDepartment of Integrated Therapy, Fudan University Shanghai Cancer Center, Shanghai, China.
Xiaoli GuDepartment of Integrated Therapy, Fudan University Shanghai Cancer Center, Shanghai, China.
Minghui LiuDepartment of Integrated Therapy, Fudan University Shanghai Cancer Center, Shanghai, China.
Zhe ZhangDepartment of Integrated Therapy, Fudan University Shanghai Cancer Center, Shanghai, China.
Wenwu ChengDepartment of Integrated Therapy, Fudan University Shanghai Cancer Center, Shanghai, China.
Zhenyu WuDepartment of Biostatistics, School of Public Health, Key Laboratory of Public Health Safety and Collaborative Innovation Center of Social Risks Governance in Health, Fudan University, Shanghai, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The purpose of this study was to evaluate the count and percentage of neutrophils as prognostic indicators in advanced cancer patients undergoing palliative care. 378 consecutive patients receiving treatment at the palliative care unit of Fudan University Shanghai Cancer Center between July 2013 and October 2015 were reviewed. In 106 of these patients, the data were extended during the follow-up. The cut-off values selected for the neutrophil count and percentage were 8.0×109/L and 85%, respectively. Both a high pretreatment neutrophil count (

Indexed as

advanced cancerneutrophil countneutrophil percentagepalliative careprognostic value

Identifiers

PMID28969089
PMCPMC5610021

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.